 Henry Waxman |
Henry Waxman, who was a powerful Los Angeles Congressman, is working Washington for a Pennsylvania drug company that is positioning itself as the leader in opioid addiction treatment.
Braeburn Inc.’s new drug application for CAM2038 weekly and monthly buprenorphine formulations is currently under review by the Food and Drug Administration.
Democrat Waxman, who was involved in healthcare, environmental and technology issues, stepped down from Congress in 2015 after a 40-year career that was capped by chairing the Energy and Commerce Committee and Committee on Oversight and Government Reform.
Jeremy Sharp, who was deputy commissioner for policy planning, legislation and analysis at the FDA and counselor for science and public health for Secretaries Kathleen Sebelius and Sylvia Burwell, joins Waxman on the push for Braeburn.
In January, Braeburn received $110M in financing from a Wellington Management Co.-led group that included Deerfield Management, RA Capital Management, New Leaf Venture Partners, Rock Springs Capital and Apple Tree Partners.
Ballard Partners has signed to a represent the US unit of Rheinmetall, Germany’s biggest defense contractor, on Army procurement issues.
BGR Group signs on to provide lobbying and PR services for Terzo, an AI financial intelligence platform. Douglas Lute, chair of BGR’s international and defense practices, will join Terzo’s board of directors.
Avoq has landed Palantir Technologies, the controversial surveillance company founded by right-wing billionaire Peter Thiel, as a client.
Anne Kierig, who was senior manager of public policy at Amazon, has joined the American Advertising Federation as VP-government affairs. She takes over for Clark Rector, who is retiring after a 37-year run at AAF.
TikTok USDS Joint Venture LLC, which was established in compliance with the executive order signed by President Trump, has hired Valcour LLC, which has close ties with his administration.
